The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“Liposomes have been used as drug delivery systems since the 1960s [69].”
MethodCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
The Hydrophobic Effect: Formation of Micelles and Biological Membranes
Tanford, C. (1991) · Medical Entomology and Zoology · Cited by 3,327
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V., Brivanlou, A. H., & Libchaber, A. (2002) · Science · doi:10.1126/science.1077194 · Cited by 3,019
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Hawker, C. J., & Frechet, J. M. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00177a027 · Cited by 2,413
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175
Poly-ϵ-caprolactone microspheres and nanospheres: an overview
Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R., & Trehan, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.044 · Cited by 1,100
Liposomes : a practical approach
New, R. R. C. (1990) · Medical Entomology and Zoology · Cited by 1,088
Patel, H. M. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81487-9 · Cited by 1,001
Roy, I., Ohulchanskyy, T. Y., Pudavar, H. E., Bergey, E. J., Oseroff, A. R., Morgan, J., Dougherty, T. J., & Prasad, P. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0343095 · Cited by 929
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Large unilamellar liposomes with low uptake into the reticuloendothelial system
Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Shuai, X., Ai, H., Nasongkla, N., Kim, S., & Gao, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.003 · Cited by 695
Voura, E. B., Jaiswal, J. K., Mattoussi, H., & Simon, S. M. (2004) · Nature Medicine · doi:10.1038/nm1096 · Cited by 688
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Pluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Polymeric micelle for tumor pH and folate-mediated targeting
Lee, E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00239-6 · Cited by 618
Galindo-Rodriguez, S., Allémann, E., Fessi, H., & Doelker, E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036917.75634.be · Cited by 602
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Nanostructure-mediated drug delivery
Hughes, G. A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2004.11.009 · Cited by 561
Lasic, D. D., Martin, F. J., Gabizon, A., Huang, S. K., & Papahadjopoulos, D. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90162-2 · Cited by 545
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
Extracellular pH distribution in human tumours
Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., & McFarlane, J. D. (1995) · International Journal of Hyperthermia · doi:10.3109/02656739509022457 · Cited by 530
Biological applications of dendrimers
Cloninger, M. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00400-3 · Cited by 516
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · cited 5×
“Usually, the molecular weight of PEG (the outer corona component) is higher than the molecular weight of the hydrophobic coreforming block [99].”
BackgroundInfluentialYang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
PEG-based micelles as carriers of contrast agents for different imaging modalities
Torchilin, V. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00019-4 · Cited by 470
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Drug targeting using thermally responsive polymers and local hyperthermia
Meyer, D. E., Shin, B. C., Kong, G. A., Dewhirst, M. W., & Chilkoti, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00319-4 · Cited by 416
Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382 · cited 1×
“Among the Pluronic micellar formulations, the formulation of doxorubicin and a mixture of L61 (PEO80-PPO27PEO80], and F127 Pluronic (PEO101-PPO56-PEO101) (SP1049C) is most advanced and is now tested in Phase I clinical trial [120].”
BackgroundCurrent methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Nanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino, F., Brignole, C., Marimpietri, D., Cilli, M., Gambini, C., Ribatti, D., Longhi, R., Allen, T. M., Corti, A., & Ponzoni, M. (2003) · PubMed · Cited by 296
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Forssen, E., & Willis, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00083-5 · Cited by 287
Harashima, H., Sakata, K., Funato, K., & Kiwada, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018965121222 · Cited by 284
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Vauthier, C. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.005 · Cited by 283
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
McAllister, K., Sazani, P., Adam, M., Cho, M. J., Rubinstein, M., Samulski, R. J., & DeSimone, J. M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027759q · Cited by 273
Batrakova, E. V., Li, S., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043307 · Cited by 263
Kobayashi, H., Kawamoto, S., Jo, S.-K., Bryant, H. L., Brechbiel, M. W., & Star, R. A. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025633c · Cited by 262
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
Kakizawa, Y., Harada, A., & Kataoka, K. (2001) · Biomacromolecules · doi:10.1021/bm000142l · Cited by 256
Ashok, B., Arleth, L., Hjelm, R. P., Rubinstein, I., & Önyüksel, H. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20150 · Cited by 255
Self-citationLe Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.018 · Cited by 255
Drug Delivery Systems: Past, Present, and Future
Mainardes, R., & Silva, L. (2004) · Current Drug Targets · doi:10.2174/1389450043345407 · Cited by 249
Liposome—complement interactions in rat serum: implications for liposome survival studies
Devine, D. V., Wong, K., Serrano, K., Chonn, A., & Cullis, P. R. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90231-3 · Cited by 248
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Lukyanov, A. N., Gao, Z., Mazzola, L., & Torchilin, V. P. (2002) · Pharmaceutical Research · doi:10.1023/a:1020488012264 · Cited by 227
Structure/Function Relationships of Polyamidoamine/DNA Dendrimers as Gene Delivery Vehicles
Braun, C. S., Vetro, J. A., Tomalia, D. A., Koe, G. S., Koe, J. G., & Russell Middaugh, C. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20251 · Cited by 225
Wang, W., & Asher, S. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja011262j · Cited by 216
Amphiphilic poly-N-vinylpyrrolidones:
Torchilin, V. P., Levchenko, T. S., Whiteman, K. R., Yaroslavov, A. A., Tsatsakis, A. M., Rizos, A. K., Michailova, E. V., & Shtilman, M. I. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00050-3 · Cited by 214
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Zara, G. P., Cavalli, R., Bargoni, A., Fundarò, A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Drug Targeting · doi:10.1080/10611860290031868 · Cited by 207
Maruyama, K., Ishida, O., Kasaoka, S., Takizawa, T., Utoguchi, N., Shinohara, A., Chiba, M., Kobayashi, H., Eriguchi, M., & Yanagie, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.018 · Cited by 207
Takeuchi, H., Kojima, H., Yamamoto, H., & Kawashima, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00368-6 · Cited by 205
PAMAM-PEG-PAMAM: Novel Triblock Copolymer as a Biocompatible and Efficient Gene Delivery Carrier
Kim, T.-I., Seo, H. J., Choi, J. S., Jang, H.-S., Baek, J.-U., Kim, K., & Park, J.-S. (2004) · Biomacromolecules · doi:10.1021/bm049563j · Cited by 204
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes
Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., & Zalipsky, S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00056-4 · Cited by 202
Drug delivery in polymeric micelles: from in vitro to in vivo
Rapoport, N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00218-9 · Cited by 192
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00237-x · Cited by 186
(1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9 · Cited by 185
Verschraegen, C. F., Gilbert, B. E., Loyer, E., Huaringa, A., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183
Human serum albumin–polyethylenimine nanoparticles for gene delivery
Rhaese, S., von Briesen, H., Rübsamen-Waigmann, H., Kreuter, J., & Langer, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00302-x · Cited by 180
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Liposome-based approaches to overcome anticancer drug resistance
Mamot, C., Drummond, D. C., Hong, K., Kirpotin, D. B., & Park, J. W. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00082-7 · Cited by 170
Zamboni, W. C., Gervais, A. C., Egorin, M. J., Schellens, J. H. M., Zuhowski, E. G., Pluim, D., Joseph, E., Hamburger, D. R., Working, P. K., Colbern, G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0719-4 · Cited by 165
Determinants of drug delivery and transport to solid tumors
Au, J. L.-S., Jang, S. H., Zheng, J., Chen, C.-T., Song, S., Hu, L., & Wientjes, M. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00308-x · Cited by 164
Size of IgG-Opsonized Particles Determines Macrophage Response during Internalization
Koval, M., Preiter, K., Adles, C., Stahl, P. D., & Steinberg, T. H. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4110 · Cited by 163
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
Mitra, A., Mulholland, J., Nan, A., McNeill, E., Ghandehari, H., & Line, B. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.023 · Cited by 162
Zweers, M. L. T., Engbers, G. H. M., Grijpma, D. W., & Feijen, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.008 · Cited by 162
Li, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., Choi, H. S., Doede, T., Chu, P., Ning, S., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.057 · Cited by 161
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 160
Formation and stability of nano-emulsions
TADROS, T. (2004) · Advances in Colloid and Interface Science · doi:10.1016/s0001-8686(03)00157-x · Cited by 159
Ultrasonically activated chemotherapeutic drug delivery in a rat model.
Nelson, J. L., Roeder, B. L., Carmen, J. C., Roloff, F., & Pitt, W. G. (2002) · PubMed · Cited by 158
Chauhan, A. S., Jain, N. K., Diwan, P. V., & Khopade, A. J. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010655 · Cited by 158
A Novel Polyacrylamide Magnetic Nanoparticle Contrast Agent for Molecular Imaging using MRI
Moffat, B. A., Reddy, G. R., McConville, P., Hall, D. E., Chenevert, T. L., Kopelman, R. R., Philbert, M., Weissleder, R., Rehemtulla, A., & Ross, B. D. (2003) · Molecular Imaging · doi:10.1162/15353500200303163 · Cited by 158
Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).
Working, P. K., & Dayan, A. D. (1996) · PubMed · Cited by 156
Krishnadas, A., Rubinstein, I., & Önyüksel, H. (2003) · Pharmaceutical Research · doi:10.1023/a:1022243709003 · Cited by 152
Self-citationChien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700793 · Cited by 152
3H Dendrimer Nanoparticle Organ/Tumor Distribution
Nigavekar, S. S., Sung, L. Y., Llanes, M., El-Jawahri, A. R., Lawrence, T. S., Becker, C. W., Balogh, L. P., & Khan, M. K. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019302.26097.cc · Cited by 150
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Dendrimer-Based Nanosized MRI Contrast Agents
Kobayashi, H., & Brechbiel, M. W. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376571 · Cited by 144
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
Dingler, A., & Gohla, S. (2002) · Journal of Microencapsulation · doi:10.1080/02652040010018056 · Cited by 143
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00211-6 · Cited by 143
Woodle, M. C. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90069-f · Cited by 142
Gene delivery by dendrimers operates via a cholesterol dependent pathway
Manunta, M., Tan, P., Sagoo, P., Kashefi, K., & George, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh595 · Cited by 141
Vu, T. Q., Maddipati, R., Blute, T. A., Nehilla, B. J., Nusblat, L. M., & Desai, T. A. (2005) · Nano Letters · doi:10.1021/nl047977c · Cited by 140
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles
Wartlick, H., Spänkuch, B., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.029 · Cited by 137
Allen, T. M., & Everest, J. M. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21638-x · Cited by 137
Reubi, J. C. (1995) · PubMed · Cited by 135
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells
Zhang, L., Hou, S., Mao, S., Wei, D., Song, X., & Lü, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.015 · Cited by 134
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
Gabizón, A., Peretz, T., Sulkes, A., Amselem, S., Ben‐Yosef, R., Ben-Baruch, N. E., Catane, R., Biran, S., & Barenholz, Y. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90350-7 · Cited by 130
Stability and release performance of a series of pegylated copolymeric micelles
Lin, W.-J., Juang, L.-W., & Lin, C.-C. (2003) · Pharmaceutical Research · doi:10.1023/a:1023215320026 · Cited by 125
Sensitization of Cells Overexpressing Multidrug-Resistant Proteins by Pluronic P85
Batrakova, E. V., Li, S., Alakhov, V. Y., Elmquist, W. F., Miller, D. W., & Kabanov, A. V. (2003) · Pharmaceutical Research · doi:10.1023/a:1026179132599 · Cited by 125
Miller, D. W., Batrakova, E. V., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018873702411 · Cited by 124
Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules
Santos-Magalhães, N. S., Pontes, A. S., Pereira, V. M. W., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00546-9 · Cited by 123
Novel Long-Circulating Lipid Nanocapsules
Hoarau, D., Delmas, P., David, S., Roux, E., & Leroux, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045229.87844.21 · Cited by 121
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies
Dagar, S., Krishnadas, A., Rubinstein, I., Blend, M. J., & Onyüksel, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00242-6 · Cited by 119
Self-citationBarreiro-Iglesias, R., Bromberg, L. E., Temchenko, M., Hatton, T. A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.007 · Cited by 118
Li, Y., & Kwon, G. S. (2000) · Pharmaceutical Research · doi:10.1023/a:1007529218802 · Cited by 117
Kang, B. K., Chon, S. K., Kim, S. H., Jeong, S. Y., Kim, M. S., Cho, S. H., Lee, H. B., & Khang, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.008 · Cited by 115
Pharmacokinetics of paclitaxel-containing liposomes in rats
Fetterly, G. J., & Straubinger, R. M. (2003) · AAPS PharmSci · doi:10.1208/ps050432 · Cited by 112
Cross-linked polyvinylpyrrolidone nanoparticles: a potential carrier for hydrophilic drugs
Bharali, D. J., Sahoo, S. K., Mozumdar, S., & Maitra, A. (2003) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(02)00099-1 · Cited by 112
Leo, E., Brina, B., Forni, F., & Vandelli, M. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.002 · Cited by 111
Cellular Fate of a Modular DNA Delivery System Mediated by Silica Nanoparticles
Gemeinhart, R. A., Luo, D., & Saltzman, W. M. (2005) · Biotechnology Progress · doi:10.1021/bp049648w · Cited by 108
Toxicological evaluation of poloxamer vehicles for intramuscular use.
Johnston, T. P., & Miller, S. C. (1985) · PubMed · Cited by 107
In VitroandIn VivoStudy of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
Peira, E., Marzola, P., Podio, V., Aime, S., Sbarbati, A., & Gasco, M. R. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086108 · Cited by 102
Seki, J., Sonoke, S., Saheki, A., Fukui, H., Sasaki, H., & Mayumi, T. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.022 · Cited by 101
Effect of colloidal carriers on ascorbyl palmitate stability
Kristl, J., Volk, B., Gašperlin, M., Šentjurc, M., & Jurkovič, P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00104-0 · Cited by 101
Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine
Koo, O. M. Y., Rubinstein, I., & Önyüksel, H. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.002 · Cited by 99
Self-citationExtravasation of Poly(amidoamine) (pamam) Dendrimers Across Microvascular Network Endothelium
ElSayed, M. E. H., Kiani, M. F., Naimark, M. D., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011066408283 · Cited by 94
A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides
Hussain, M., Shchepinov, M. S., Sohail, M. F., Benter, I. F., Hollins, A. J., Southern, E. M., & Akhtar, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.009 · Cited by 91
Rudin, C. M., Marshall, J. L., Huang, C. H., Kindler, H. L., Zhang, C., Kumar, D., Gokhale, P. C., Steinberg, J., Wanaski, S., Kasid, U. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0642 · Cited by 90
Controlled release technologies for drug delivery
Brayden, D. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02874-5 · Cited by 89
Micelles in Anticancer Drug Delivery
Garrec, D. E. L., Ranger, M., & Leroux, J. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402010-00002 · Cited by 87
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Ni, S., Stephenson, S. M., & Lee, R. J. (2002) · PubMed · Cited by 83
Hollins, A. J., Benboubetra, M., Omidi, Y., Zinselmeyer, B. H., Schätzlein, A. G., Uchegbu, I. F., & Akhtar, S. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019300.04836.51 · Cited by 82
Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)
Guaglianone, P. P., Chan, K. K., Delaflor–Weiss, E., Hanisch, R., Jeffers, S., Sharma, D., & Muggia, F. M. (1994) · Investigational New Drugs · doi:10.1007/bf00874439 · Cited by 81
Arnedo, A., Irache, J. M., Merodio, M., & Espuelas, S. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.009 · Cited by 80
Arleth, L., Ashok, B., Önyüksel, H., Thiyagarajan, P., Jacob, J., & Hjelm, R. P. (2005) · Langmuir · doi:10.1021/la047588y · Cited by 77
He, L., Wang, G.-L., & Zhang, Q. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00478-7 · Cited by 76
Leobandung, W., Ichikawa, H., Fukumori, Y., & Peppas, N. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00028-7 · Cited by 73
Omori, N., Maruyama, K., Jin, G., Wang, S., Hamakawa, Y., Sato, K., NAGANO, I., Shoji, M., & Abe, K. (2003) · Neurological Research · doi:10.1179/016164103101201508 · Cited by 72
Endothelial barriers: from hypothetical pores to membrane proteins*
Firth, J. A. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00059.x · Cited by 70
Design and characterisation of new nanoparticulate polymer blends for drug delivery
Csaba, N., Gonzalez, L., Sánchez, A., & Alonso, M. J. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562041753098 · Cited by 67
Treatment of experimental osteomyelitis by liposomal antibiotics
Kadry, A. A., Al‐Suwayeh, S. A., Abd‐Allah, A. R. A., & Bayomi, M. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh465 · Cited by 65
Sequestration and Ultrasound-Induced Release of Doxorubicin from Stabilized Pluronic P105 Micelles
Pruitt, J. D., & Pitt, W. G. (2002) · Drug Delivery · doi:10.1080/10717540260397873 · Cited by 63
Dendrimer grafts for delivery of 5-fluorouracil.
Pk, T., Khopade, A. J., Nagaich, S., Shrivastava, S. K., Jain, S., & Nk, J. (2002) · PubMed · Cited by 61
Liposome-Encapsulated MTP-PE: A Novel Biologic Agent for Cancer Therapy
Asano, T., & Kleinerman, E. S. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199311000-00006 · Cited by 60
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
Medina, O. P., Kairemo, K., Valtanen, H., Kangasniemi, A., Kaukinen, S., Ahonen, I., Permi, P., Annila, A., Sneck, M., Holopainen, J. M., et al. (2005) · PubMed · Cited by 56
Dagar, S., Sekosan, M., Lee, B. S., Rubinstein, I., & Önyüksel, H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00326-1 · Cited by 55
Self-citationImproved Paclitaxel Formulation Hints at New Chemotherapy Approach
Garber, K. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/96.2.90 · Cited by 55
Test of a two-pathway model for small-solute exchange across the capillary wall
Fu, B. M., Adamson, R. H., & CURRY, F. E. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.6.h2062 · Cited by 55
Cavallaro, G., Maniscalco, L., Licciardi, M., & Giammona, G. (2004) · Macromolecular Bioscience · doi:10.1002/mabi.200400089 · Cited by 53
Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles
Husseini, G. A., Runyan, C. M., & Pitt, W. G. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-20 · Cited by 52
A novel delivery system for amphotericin B with lipid nano-sphere (LNS®)
Fukui, H., Koike, T., Saheki, A., et al. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00404-6 · Cited by 49
Fonseca, M. J., Jagtenberg, J. C., Haisma, H. J., & Storm, G. (2003) · Pharmaceutical Research · doi:10.1023/a:1022608321861 · Cited by 45
New systems for delivery of drugs to the brain in neurological disease
Cornford, E. M., & Cornford, M. E. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00136-9 · Cited by 43
Superparamagnetic iron oxide: clinical time-response study
Gandon, Y., Heautot, J.-F., Brunet, F., Guyader, D., Deugnier, Y., & Carsin, M. (1991) · European Journal of Radiology · doi:10.1016/0720-048x(91)90072-4 · Cited by 41
Séjourné, F., Rubinstein, I., Suzuki, H., & Alkan-Önyüksel, H. (1997) · Pharmaceutical Research · doi:10.1023/a:1012062424662 · Cited by 38
Self-citationMoody, T. W., Leyton, J., Gozes, I., Láng, L., & Eckelman, W. C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11189.x · Cited by 30
Brime, B. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg266 · Cited by 28
In Vitro Identification of VIP Receptors in Human Tumors: Potential Clinical Implications
Reubi, J. C. (2006) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb17553.x · Cited by 23
Basement membrane and β amyloid fibrillogenesis in Alzheimer's disease
Inoué, S. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)10005-7 · Cited by 20
Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis
Oki, T., Takahashi, S., Kuwabara, S., Yoshiyama, Y., Mori, M., Hattori, T., & Suzuki, N. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.026 · Cited by 19
Liposomes in Ultrasound and Gamma Scintigraphic Imaging
Dagar, S., Rubinstein, I., & Önyüksel, H. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)73013-4 · Cited by 14
Self-citationInteractions of VIP with rigid phospholipid bilayers: implications for vasoreactivity
Önyüksel, H., Ashok, B., Dagar, S., et al. (2003) · Peptides · doi:10.1016/s0196-9781(03)00033-0 · Cited by 10
Ojugo (1999) · doi:10.1002/(sici)1099-1492(199912)12:8
Cited by
Potential perspectives of bio-nanocomposites for food packaging applications
Sorrentino, A., Gorrasi, G., & Vittoria, V. (2007) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2006.09.004 · Cited by 1,112
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
Nativo, P., Prior, I. A., & Brust, M. (2008) · ACS Nano · doi:10.1021/nn800330a · Cited by 659
Application of Nanotechnology in Food Science: Perception and Overview
Singh, T., Shukla, S., Kumar, P., Wahla, V., Bajpai, V. K., & Rather, I. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01501 · Cited by 652
Metadata
- Authors
- Koo, O. M., Rubinstein, I., & Onyuksel, H.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 1
- Issue
- 3
- Pages
- 193-212
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2038998098
- Cited by
- 718
- References
- 186
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.